Why did you apply for the EADV presidency?
What do you hope you can bring to the role?
Tell us about your presentation in the autoimmune disorders session at this year’s congress
What advances are being made in dermatomytosis?
And what medical needs remain?
What goals did you set for your EADV presidency?
What issues are you using the platform to raise awareness of?
How much focus is there on metastatic melanoma?
What novel approaches are we seeing in immunotherapy for metastatic melanoma?